Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Work In Process (2018 - 2025)

Jaguar Health (JAGX) has disclosed Work In Process for 8 consecutive years, with $7.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Work In Process rose 5.66% to $7.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $7.4 million, a 5.66% increase, with the full-year FY2024 number at $7.4 million, up 13.66% from a year prior.
  • Work In Process was $7.4 million for Q3 2025 at Jaguar Health, down from $7.6 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $7.7 million in Q1 2025 to a low of $1.5 million in Q1 2021.
  • A 5-year average of $4.9 million and a median of $5.4 million in 2023 define the central range for Work In Process.
  • Peak YoY movement for Work In Process: soared 306.27% in 2021, then grew 5.66% in 2025.
  • Jaguar Health's Work In Process stood at $2.8 million in 2021, then skyrocketed by 30.4% to $3.6 million in 2022, then soared by 81.08% to $6.5 million in 2023, then increased by 13.66% to $7.4 million in 2024, then dropped by 0.01% to $7.4 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Work In Process are $7.4 million (Q3 2025), $7.6 million (Q2 2025), and $7.7 million (Q1 2025).